Table 4 Data on use and safety of finished products
Variables | Frequency, n (%) |
|---|---|
Routes of administration (na = 133) | |
Oral | 95 (71.4) |
Topical dermal | 19 (14.2) |
Inhalation | 9 (6.8) |
Bath | 5 (3.8) |
Rectal | 3 (2.3) |
Auricular | 2 (1.5) |
Existence of dosage (n = 123) | |
No | 44 (35.8) |
Yes | 79 (64.2) |
Age and gender dependent dosage (n = 121) | |
No | 62 (51.2) |
Yes | 59 (48.8) |
Number of daily intakes (n = 129) | |
1 | 36 (27.9) |
2 | 57 (44.2) |
3 | 34 (26.4) |
> 3 | 2 (1.6) |
Material or mode of dosing (n = 92) | |
Tablespoon | 30 (32.6) |
Glass | 23 (25) |
Pinch | 18 (19.6) |
Coffee spoon | 5 (5.4) |
Calabash | 3 (3.3) |
Handle | 3 (3.3) |
Capsule | 2 (2.2) |
Cup | 2 (2.2) |
Sip | 2 (2.2) |
Measuring bottle | 1 (1.1) |
Soaked cotton | 1 (1.1) |
Drop | 1 (1.1) |
Rectal enema pear | 1 (1.1) |
Treatment duration (days) (n = 111) | |
≤ 5 | 49 (44.2) |
6 – 10 | 26 (23.4) |
11 – 15 | 10 (9) |
> 15 | 26 (23.4) |
Can be used during pregnancy or breastfeeding (n = 121) | |
No | 46 (38) |
Yes | 75 (62) |
Expected adverse events (n = 28) | |
Gastrointestinal disorders (diarrhea, vomiting, abdominal pain, nausea, burping) | 15 (54) |
Dizziness | 3 (11) |
Muscle pain | 2 (7) |
Drowsiness | 2 (7) |
Skin flaking | 2 (7) |
Large diuresis | 2 (7) |
Headache | 1 (3.5) |
Temporary giddiness | 1 (3.5) |
Effects of overdose (n = 38) | |
Gastrointestinal disorders (diarrhoea, vomiting, bloating, constipation, nausea) | 23 (60.5) |
Vertigo | 3 (8) |
Hypersudation | 2 (5.3) |
Body pain | 2 (5.3) |
Palpitation | 1 (2.6) |
Headache | 1 (2.6) |
Heavy diuresis | 1 (2.6) |
Sneezing | 1 (2.6) |
Fever | 1 (2.6) |
Limbs inflammation | 1 (2.6) |
Irritation of the tongue | 1 (2.6) |
Discomfort | 1 (2.6) |